- Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PloS one. 2012 Academic Article GET IT
- A phase II trial of sorafenib in metastatic melanoma with tissue correlates. PloS one. 2010 Academic Article GET IT
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo.
Journal of translational medicine.
Times cited: 44
Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.
Journal of Molecular Diagnostics.
Times cited: 26